On the question of the treatment of chronic hepatitis C with HIV co-infection in patients with lymphoma
Due to the use of HAART, the efficacy of the treatment of AIDS-related lymphomas and indicators of survival in patients are close to those in the general population of lymphoma patients without HIV. According to the data of department of hematology and secondary immunodeficient conditions of Moscow...
Main Authors: | A V Chistyakova, N I Stuklov, M V Tumanova, M G Dubnitskaya, O V Mukhin, E P Shtyrlina, A V Pivnik |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2016-12-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/27111 |
Similar Items
-
Analysis of inpatient care for HIV-positive patients with malignant lymphomas and hepatitis over 5 years (2011—2015) at the A.S.Loginov Moscow Clinical Research Center, Moscow Healthcare Department
by: A V Pivnik, et al.
Published: (2017-07-01) -
Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil
by: Maria Cássia Mendes-Corrêa, et al. -
HIV and Hepatitis C Virus Coinfection, Cameroon
by: Christian Laurent, et al.
Published: (2007-03-01) -
Evolution of hepatitis B serological markers in HIV coinfected patients: a case study
by: Ana Luiza de Castro Conde Toscano, et al. -
Hepatitis B and hepatitis C prevalence among people living with HIV/AIDS in China: a systematic review and Meta-analysis
by: Songxia Yu, et al.
Published: (2020-08-01)